Peter Neems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint

The AcQBlate Force Sensing Ablation Catheter and System demonstrated 94% acute success with no serious adverse events and significantly less ablation time.

United statesPeter neemsCardiovasc electrophysiolDavid romanAcutus medical incSensing rf ablationElectrophysiologist at baptist health lexingtonFlutter studyForce sensingLow flow gold tip catheterLate breaking clinical trialsFirst report investigationsGery tomassoniBaptist health lexingtonAcutus medicalFlutter trial clinical results

Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium

Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPeter neemsCardiovasc electrophysiolAcutus medical incSensing rf ablationAcqblate force sensing ablation catheterFlutter trial clinical resultsForce sensingLow flow gold tip catheterLate breaking clinical trialsFirst report investigationsForce sensing ablation catheterAcutus medicalGold comparedPlatinum tip irrigated catheter ablationPulmonary veins

Acutus Medical Achieves EU MDR Submission Milestone in Sale

CARLSBAD, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company.

United statesPeter neemsDavid romanExchange commissionAcutus medical incEuropean union eu medical device regulationsCompany nasdaqEuropean unionMedical device regulationsAcutus medicalNasdaq afibAcutus medical